本文已被:浏览 121次 下载 145次
Received:December 03, 2025 Published Online:June 28, 2026
Received:December 03, 2025 Published Online:June 28, 2026
中文摘要: 目的 探讨基于数据挖掘的糖尿病肾病中医药治疗用药规律。方法 收集2013年1月至2024年12月中国知网(CNKI)、维普中文科技期刊数据库(VIP)、万方数据库、中国中医药期刊文献数据库中关于中医治疗糖尿病肾病的医案药方,使用Excel软件构建数据库,应用中医药数据挖掘系统进行用药频次、药性、药味、归经、功效、层次聚类、关联及复杂网络分析,并探究同一聚类药物的配伍规律及意义。结果 本研究基于纳入标准和排除标准共筛选327篇中医药治疗糖尿病肾病的文献。所纳入的文献涉及中药处方327首,205味中药,用药频次2624次,根据使用频次进行排序,用药频次前10位的药物依次为黄芪、茯苓、丹参、山药、山茱萸、当归、大黄、熟地黄、白术、川芎。药物药性以寒性、温性为主,药味以甘、苦为主,多归肝经、肾经、脾经。205味中药根据功效可分为17类,其中频率最高的前五位分别为补虚药、活血化瘀药、利水渗湿药、清热药和收涩药。使用Apriori算法挖掘药对组合,最终得到29条关联组合,其中频次最高的2味药组合为黄芪-茯苓、黄芪-丹参、黄芪-当归、黄芪山药、黄芪-山茱萸,频次最高的3味药组合为黄芪-茯苓-山茱萸、黄芪-茯苓-山药、黄芪-茯苓-泽泻、黄芪-山药-丹参、黄芪-山药-泽泻。使用复杂系统熵聚类法分析核心组合,得到10个中药治疗糖尿病肾病的核心组合;使用熵聚类及改进互信法挖掘新方组合,得到5个治疗糖尿病肾病的新方组合。结论 黄芪、茯苓、丹参、山药、山茱萸等为现代医家治疗糖尿病肾病的高频核心药物,中医治疗糖尿病肾病多以补虚药为主,同时配合活血化瘀药、利水渗湿药、清热药、收涩药等以达到标本兼治的作用,药对组合、核心组合、新方组合进一步揭示了中医药治疗糖尿病肾病的常用配伍规律,为中医药治疗糖尿病肾病提供了新的思路和方法。
Abstract:Objective To investigate the medication patterns of Chinese medicine in treating diabetic nephronpathy through data mining analysis. Methods A comprehensive collection of medical prescriptions for Chinese medicine treatment of diabetic nephropathy was gathered from databases including CNKI, VIP, Wanfang, and the Chinese Journal of Traditional Chinese Medicine Literature Database from January 2013 to December 2024. An Excel-based database was constructed, and a Chinese medicine data mining system was applied to conduct frequency analysis, medicinal nature and flaver classification, meridian entry, efficacy categorization, hierarchical clustering, association rules, and complex network analysis. The compatibility patterns and significance within the same cluster were also explored. Results According to established inclusion and exclusion criteria, 327 articles on Chinese medicine treatment for diabetic nephropathy were selected, involving 327 prescriptions and 205 types of herbs with a cumulative usage frequency of 2 624 times. The top ten most frequently used herbs are Astragalus, Poria, Salvia miltiorrhiza, Dioscorea, Cornus officinalis, Angelica sinensis, Rheum palmatum, Rehmannia glutinosa, Atractylodes macrocephala, and ligusticum chuanxiong. These herbs predominantly exhibit cold or warm properties and are mainly sweet or bitter in flaver, mostly entering the liver, kidney, and spleen entry. The 205 herbs can be categorized into 17 classes based on their efficacy, with the highest frequencies being tonifying herbs, blood-activating and stasis-resolving herbs, urine excretion to strain off dampness herbs, heat-clearing herbs, and astringent herbs. The Apriori algorithm was used to mine herb pair combinations, and 29 association rules were finally obtained. Among them, the most frequent two-herb combinations were Astragalus - Poria, Astragalus - Salvia miltiorrhiza, Astragalus - Angelica sinensis, Astragalus -Dioscorea, and Astragalus-Cornus officinalis;the most frequent three-herb combinations were Astragalus-Poria-Cornus officinalis, Astragalus - Poria - Dioscorea, Astragalus - Poria - Alisma, Astragalus - Dioscorea - Salvia miltiorrhiza, and Astragalus-Dioscorea-Alisma. Complex system entropy clustering identified 10 core Chinese medicine combinations for treating diabetic nephropathy, while 5 new formulae were discovered by entropy clustering and improved mutual information method. Conclusion Astragalus, Poria, Salvia miltiorrhiza, Dioscorea, and Cornus officinalis are among the high-frequency core medications used by modern physicians in the treatment of diabetic nephropathy. Chinese medicine treatments for diabetic nephropathy mainly focus on tonifying drugs, complemented by blood-activating and stasis-resolving drugs, diuretic and dampness-resolving drugs, heat-clearing drugs, and astringent drugs to achieve both symptomatic and radical treatment. The pairing of drugs, core combinations, and new formula combinations further illuminate the common compatibility rules of Chinese medicine in treating diabetic nephropathy, providing new perspectives and methodologies for its treatment.
文章编号: 中图分类号:R259 R587.2 文献标志码:A
基金项目:河北省中医药类科研计划课题(2021418)
引用文本:
